Health
Oxford-AstraZeneca vaccine effective against B.1.1.7 SARS-CoV-2 variant – News-Medical.Net
Published in The Lancet, the study explores if the Oxford-AstraZeneca vaccine works well in protecting against the B.1.1.7 variant, otherwise known as the U.K….
The coronavirus disease (COVID-19) pandemic continues to spread globally, with new variants emerging. One of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants is the B.1.1.7 or U.K. variant. It is still unclear if the developed vaccines can protect against new emerging variants.
Now, researchers at the COVID-19 Genomics United Kingdom Consortium, the AMPHEUS Project, and the Oxford COVID-19 Vaccine Trial Group released the results of their exploratory analysis of a randomized…
-
General20 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General23 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News22 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business19 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher